ATAI Life Sciences NV (9VC) — Strategic Asset Allocation Index
ATAI Life Sciences NV (9VC) has a Strategic Asset Allocation Index of 55.3% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €88.36 Million) total €88.36 Million, measured against net assets of €159.91 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check how resilient are ATAI Life Sciences NV's assets to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
ATAI Life Sciences NV Strategic Asset Allocation Index (2019–2024)
This chart shows how ATAI Life Sciences NV's Strategic Asset Allocation Index has evolved across 6 annual periods from 2019 to 2024. As of September 2025, the index stands at 55.3%, representing strategic assets of €88.36 Million against net assets of €159.91 Million EUR. See ATAI Life Sciences NV (9VC) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for ATAI Life Sciences NV (2019–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for ATAI Life Sciences NV from 2019 to 2024, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market value of ATAI Life Sciences NV.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 60.9% | €70.97 Million | €- | €70.97 Million | €116.55 Million | ▲ +23.4 pp |
| 2023 | 37.5% | €91.66 Million | €- | €91.66 Million | €244.32 Million | ▲ +35.0 pp |
| 2022 | 2.5% | €6.75 Million | €- | €6.75 Million | €265.77 Million | ▼ -4.7 pp |
| 2021 | 7.2% | €27.76 Million | €- | €27.76 Million | €385.96 Million | ▼ -1.2 pp |
| 2020 | 8.4% | €8.04 Million | €- | €8.04 Million | €95.37 Million | ▼ -30.0 pp |
| 2019 | 38.5% | €22.95 Million | €- | €22.95 Million | €59.64 Million | — |